M&A Deal Summary

Grünenthal Acquires Nebido

On July 14, 2022, Grünenthal acquired life science company Nebido from Bayer for 500M EUR

Acquisition Highlights
  • This is Grünenthal’s 5th transaction in the Life Science sector.
  • This is Grünenthal’s 0th largest (disclosed) transaction.
  • This is Grünenthal’s 2nd transaction in Germany.

M&A Deal Summary
Date 2022-07-14
Target Nebido
Sector Life Science
Buyer(s) Grünenthal
Sellers(s) Bayer
Deal Type Divestiture
Deal Value 500M EUR

Target

Nebido

Leverkusen, Germany
Nebido provides treatment of male hypogonadism (testosterone deficiency) is based in Leverkusen, Germany.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grünenthal

Aachen, Germany
Category Company
Sector Life Science
DESCRIPTION

Grünenthal GmbH is an independent, family-owned, international research-based pharmaceutical company.

DEAL STATS #
Overall 7 of 8
Sector (Life Science) 5 of 6
Type (Divestiture) 2 of 2
Country (Germany) 2 of 2
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-12 Mestex AG

Basel, Switzerland

Mestex is a cluster for innovative pharmaceutical industries and biotech companies in Europe. The company with its brand Lopain provides solutions to all patients suffering from osteoarthritis-related joint pain. Mestex is based in Basel, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-22 Valinor

Chicago, Illinois, United States

Valinor is a pharmaceutical company focused on innovative commercialization of medicines. Valinor is based in Chicago, Illinois.

Buy $250M

Seller(S) 1

SELLER

Bayer

Leverkusen, Germany
Category Company
Founded 1863
Sector Life Science
Employees98,189
Revenue 47.6B EUR (2023)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 20 of 23
Sector (Life Science) 5 of 6
Type (Divestiture) 16 of 19
Country (Germany) 11 of 12
Year (2022) 2 of 3
Size (of disclosed) 7 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-10 Envu

Cary, North Carolina, United States

Envu is a global provider of products and services to create healthier environments, to manage pests, and to eliminate vector-borne diseases, across a range of end-markets. Envu has an extensive product portfolio to manage pests (such as rodents, pest insects and invasive weeds) in a sustainable and responsible manner, including for the vegetation management, range and pasture, forestry and turf and ornamentals markets. In addition, the business markets products to protect against vector-borne diseases such as malaria, and to promote public health objectives in the developing world. Envu is headquartered in Cary, North Carolina.

Sell $2.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-28 Axxam

Bresso, Italy

Axxam is an iPRO (innovative Partner Research Organization) and discovery company located in the scientific campus OpenZone. The Company is a provider of discovery services for the entire life sciences industry. Axxam has strong expertise across a broad range of discovery disciplines and innovative technologies, including assay development, compound management, HTS (high-throughput screening) / HCS (high content screening), hit identification and hit validation. Axxam is also engaged in developing novel innovative therapies for diseases with a high unmet medical need. Axxam was founded in 2001 and is based in Bresso, Italy.

Sell -
Mergr

Product

Company

Legal